APA (7th ed.) Citation

Krilaviciute, A., Kaaks, R., Seibold, P. B., De Vrieze, M., Lakes, J., Radtke, J. P., . . . Albers, P. (2024). Risk-adjusted screening for prostate cancer: Defining the low-risk group by data from the PROBASE trial. European urology, 86(6), . https://doi.org/10.1016/j.eururo.2024.04.030

Chicago Style (17th ed.) Citation

Krilaviciute, Agne, et al. "Risk-adjusted Screening for Prostate Cancer: Defining the Low-risk Group by Data from the PROBASE Trial." European Urology 86, no. 6 (2024). https://doi.org/10.1016/j.eururo.2024.04.030.

MLA (9th ed.) Citation

Krilaviciute, Agne, et al. "Risk-adjusted Screening for Prostate Cancer: Defining the Low-risk Group by Data from the PROBASE Trial." European Urology, vol. 86, no. 6, 2024, https://doi.org/10.1016/j.eururo.2024.04.030.